In a recent study, Macías et al. (2024) investigated the potential of detecting APOE ε4 allele-specific DNA in cfDNA as a complementary approach to traditional AD biomarkers, such as Aβ and tau proteins. Here, MAPT is linked to Alzheimer disease.